Close

Zalicus Inc. (ZLCS) Enters Merger Agreement with Epirus Biopharma

April 16, 2014 7:12 AM EDT Send to a Friend
Zalicus Inc. (Nasdaq Capital Market: ZLCS) (Zalicus), and Epirus Biopharmaceuticals, Inc. (Epirus), a Boston-based biopharmaceutical company focused on the global ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login